InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
surf1944 Free
05/05/10 10:07 AM
profile icon
dread50above Free
02/25/10 3:39 PM
profile icon
surf1944 Free
02/11/10 2:32 PM
profile icon
dread50above Free
01/09/10 11:00 AM
profile icon
surf1944 Free
12/21/09 11:53 PM
profile icon
surf1944 Free
12/18/09 9:21 AM
profile icon
makesumgravy Free
08/02/09 9:07 AM
profile icon
makesumgravy Free
08/02/09 8:40 AM
profile icon
makesumgravy Free
08/02/09 8:36 AM
profile icon
makesumgravy Free
08/02/09 8:29 AM
profile icon
makesumgravy Free
08/02/09 8:23 AM
profile icon
makesumgravy Free
08/02/09 8:11 AM
profile icon
mugur Free
07/12/07 11:11 AM
profile icon
mugur Free
07/11/07 11:56 PM

SENO SENORX, INC (SENO) RSS Feed

Followers
0
Posters
5
Posts (Today)
0
Posts (Total)
23
Created
07/11/07
Type
Free
Moderators

http://www.senorx.com

http://finance.yahoo.com/q/h?s=SENO

SenoRx was founded in 1998 to design, develop, manufacture and market minimally invasive devices for the diagnosis and treatment of breast cancer. SenoRx (NASDAQ: SENO) completed its initial public offering of common stock in March 2007. Since its founding, SenoRx has developed multiple, proprietary technology platforms and a unique product portfolio that address a range of diagnostic and therapeutic procedures. These products include the EnCor® vacuum-assisted breast biopsy system, the Contura™ Multi-Lumen Balloon (MLB) applicator for delivering radiation to the tissue surrounding the lumpectomy cavity following surgery for breast cancer, and SenoSonix, which combines ultrasound and vacuum assisted biopsy in one system. It is the goal of SenoRx to become the leader in the breast care market by offering products that dramatically enhance patient outcomes. SenoRx has placed thousands of its products in breast centers, hospitals, outpatient centers, and radiation oncology centers across the United States and Canada, and around the world.

SenoRx’s field sales organization serves over 2,000 breast diagnostic and treatment centers in the United States and Canada. In addition, SenoRx sells several of its products through distribution partners in more than 30 countries outside the U.S. and Canada. The company’s line of breast care products includes biopsy disposables, biopsy capital equipment, diagnostic adjunct products and therapeutic disposables. SenoRx is continuing development of additional minimally invasive products for the diagnosis and treatment of breast cancer.


Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
SENO Latest News
  • No Recent News Available for this company!
New Post